Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

[Authorization of tissue and blood stem cell preparations for hematopoietic reconstitution: Documentation of clinical and nonclinical data in a central expert report].

Vahlensieck U, Poley-Ochmann S, Hilger A, Heiden M, Seitz R.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1247-53. doi: 10.1007/s00103-015-2241-3. Review. German.

PMID:
26459568
2.

Functional properties of transgenic mouse hearts overexpressing both calsequestrin and the Na(+)-Ca(2+) exchanger.

Linck B, Bokník P, Huke S, Kirchhefer U, Knapp J, Lüss H, Müller FU, Neumann J, Tanriseven Z, Vahlensieck U, Baba HA, Jones LR, Philipson KD, Schmitz W.

J Pharmacol Exp Ther. 2000 Aug;294(2):648-57.

PMID:
10900244
3.

On the cardiac contractile, electrophysiological and biochemical effects of endothall, a protein phosphatase inhibitor.

Bokník P, Vahlensieck U, Huke S, Knapp J, Linck B, Lüss H, Müller FU, Neumann J, Schmitz W.

Pharmacology. 2000 Jul;61(1):43-50.

PMID:
10895080
4.

Functional studies in atrium overexpressing A1-adenosine receptors.

Neumann J, Vahlensieck U, Boknik P, Linck B, Lüss H, Müller FU, Matherne GP, Schmitz W.

Br J Pharmacol. 1999 Dec;128(7):1623-9.

5.

On the contractile function of protein phosphatases in isolated human coronary arteries.

Knapp J, Bokník P, Deng MC, Huke S, Lüss I, Klein-Wiele O, Linck B, Lüss H, Müller FU, Nacke P, Scheld HH, Schmitz W, Vahlensieck U, Neumann J.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Oct;360(4):464-72.

PMID:
10551284
6.

Inositol-1,4,5-trisphosphate increase by diadenosine tetraphosphate in preparations from failing human myocardium.

Knapp J, Bokník P, Linck B, Läer S, Müller FU, Neumann J, Vahlensieck U, Schlüter H, Zidek W, Schmitz W.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Sep;360(3):354-7.

PMID:
10543439
7.

Regional expression of phospholamban in the human heart.

Bokník P, Unkel C, Kirchhefer U, Kleideiter U, Klein-Wiele O, Knapp J, Linck B, Lüss H, Müller FU, Schmitz W, Vahlensieck U, Zimmermann N, Jones LR, Neumann J.

Cardiovasc Res. 1999 Jul;43(1):67-76.

PMID:
10536691
8.

Expression of cardiac calcium regulatory proteins in atrium v ventricle in different species.

Lüss I, Boknik P, Jones LR, Kirchhefer U, Knapp J, Linck B, Lüss H, Meissner A, Müller FU, Schmitz W, Vahlensieck U, Neumann J.

J Mol Cell Cardiol. 1999 Jun;31(6):1299-314.

PMID:
10371704
9.

The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability.

Knapp J, Bokník P, Lüss I, Huke S, Linck B, Lüss H, Müller FU, Müller T, Nacke P, Noll T, Piper HM, Schmitz W, Vahlensieck U, Neumann J.

J Pharmacol Exp Ther. 1999 Jun;289(3):1480-6.

PMID:
10336542
10.

Quantitation of clobazam in human plasma using high-performance liquid chromatography.

Knapp J, Bokník P, Gumbinger HG, Linck B, Lüss H, Müller FU, Schmitz W, Vahlensieck U, Neumann J.

J Chromatogr Sci. 1999 May;37(5):145-9.

PMID:
10335607
11.

Identification and characterization of diadenosine 5',5"'-P1,P2 -diphosphate and diadenosine 5',5"'-P1,P3-triphosphate in human myocardial tissue.

Luo J, Jankowski J, Knobloch M, Van der Giet M, Gardanis K, Russ T, Vahlensieck U, Neumann J, Schmitz W, Tepel M, Deng MC, Zidek W, Schlüter H.

FASEB J. 1999 Apr;13(6):695-705.

PMID:
10094930
12.

Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations.

Vahlensieck U, Bokník P, Gombosová I, Huke S, Knapp J, Linck B, Lüss H, Müller FU, Neumann J, Deng MC, Scheld HH, Jankowski H, Schlüter H, Zidek W, Zimmermann N, Schmitz W.

J Pharmacol Exp Ther. 1999 Feb;288(2):805-13.

PMID:
9918592
13.

Inotropic effects of diadenosine tetraphosphate in isolated canine cardiac preparations.

Neumann J, Meissner A, Bokník P, Gombosová I, Knapp J, Lüss H, Müller FU, Schlüter H, Zidek W, Rolf N, Van Aken H, Vahlensieck U, Schmitz W.

J Cardiovasc Pharmacol. 1999 Jan;33(1):151-6.

PMID:
9890411
14.

Contractility and inhibition of protein phosphatases by cantharidin.

Knapp J, Bokník P, Huke S, Gombosová I, Linck B, Lüss H, Müller FU, Müller T, Nacke P, Schmitz W, Vahlensieck U, Neumann J.

Gen Pharmacol. 1998 Nov;31(5):729-33. Review.

PMID:
9809469
15.

Identification and expression of a novel isoform of cAMP response element modulator in the human heart.

Müller FU, Bokník P, Knapp J, Neumann J, Vahlensieck U, Oetjen E, Scheld HH, Schmitz W.

FASEB J. 1998 Sep;12(12):1191-9.

PMID:
9737722
16.

Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(++)-ATPase in mammalian ventricle.

Linck B, Bokník P, Baba HA, Eschenhagen T, Haverkamp U, Jäckel E, Jones LR, Kirchhefer U, Knapp J, Läer S, Müller FU, Schmitz W, Scholz H, Syska A, Vahlensieck U, Neumann J.

J Pharmacol Exp Ther. 1998 Jul;286(1):531-8.

PMID:
9655899
17.

Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatases.

Gombosova I, Boknik P, Kirchhefer U, Knapp J, Luss H, Muller FU, Muller T, Vahlensieck U, Schmitz W, Bodor GS, Neumann J.

Am J Physiol. 1998 Jun;274(6):H2123-32. doi: 10.1152/ajpheart.1998.274.6.H2123.

PMID:
9841539
18.

The mechanism of action of cantharidin in smooth muscle.

Knapp J, Bokník P, Huke S, Lüss H, Müller FU, Müller T, Nacke P, Schmitz W, Vahlensieck U, Neumann J.

Br J Pharmacol. 1998 Mar;123(5):911-9.

19.

Quantification of the cAMP response element binding protein in ventricular nuclear protein from failing and nonfailing human hearts.

Müller FU, Bokník P, Knapp J, Lüss H, Neumann J, Vahlensieck U, Böhm M, Deng MC, Scheld HH, Schmitz W.

Biochem Biophys Res Commun. 1997 Jul 18;236(2):351-4.

PMID:
9240439
20.

The effect of the protein phosphatases inhibitor cantharidin on beta-adrenoceptor-mediated vasorelaxation.

Knapp J, Bokník P, Linck B, Lüss H, Müller FU, Nacke P, Neumann J, Vahlensieck U, Schmitz W.

Br J Pharmacol. 1997 Feb;120(3):421-8.

21.

Mechanisms of the contractile effects of levosimendan in the mammalian heart.

Bokník P, Neumann J, Kaspareit G, Schmitz W, Scholz H, Vahlensieck U, Zimmermann N.

J Pharmacol Exp Ther. 1997 Jan;280(1):277-83.

PMID:
8996207
22.

Negative chronotropic and inotropic effects exerted by diadenosine hexaphosphate (AP6A) via A1-adenosine receptors.

Vahlensieck U, Bokník P, Knapp J, Linck B, Müller FU, Neumann J, Herzig S, Schlüter H, Zidek W, Deng MC, Scheld HH, Schmitz W.

Br J Pharmacol. 1996 Nov;119(5):835-44.

23.

Effects of cantharidin on force of contraction and phosphatase activity in nonfailing and failing human hearts.

Linck B, Boknik P, Knapp J, Müller FU, Neumann J, Schmitz W, Vahlensieck U.

Br J Pharmacol. 1996 Oct;119(3):545-50.

24.

Analysis of the components of Lycopus europaeus L. in body fluids during metabolism studies. Comparison of capillary electrophoresis and high-performance liquid chromatography.

Wojciechowski H, Gumbinger HG, Vahlensieck U, Winterhoff H, Nahrstedt A, Kemper FH.

J Chromatogr A. 1995 Nov 24;717(1-2):261-70.

PMID:
8520679
25.

In vivo isoproterenol treatment leads to downregulation of the mRNA encoding the cAMP response element binding protein in the rat heart.

Müller FU, Bokník P, Horst A, Knapp J, Linck B, Schmitz W, Vahlensieck U, Walter A.

Biochem Biophys Res Commun. 1995 Oct 24;215(3):1043-9.

PMID:
7488029
26.

cAMP response element binding protein is expressed and phosphorylated in the human heart.

Müller FU, Bokník P, Horst A, Knapp J, Linck B, Schmitz W, Vahlensieck U, Böhm M, Deng MC, Scheld HH.

Circulation. 1995 Oct 15;92(8):2041-3.

PMID:
7554179
27.

The effect of Chelidonium majus herb extract on choleresis in the isolated perfused rat liver.

Vahlensieck U, Hahn R, Winterhoff H, Gumbinger HG, Nahrstedt A, Kemper FH.

Planta Med. 1995 Jun;61(3):267-71.

PMID:
7617771
28.

Endocrine effects of Lycopus europaeus L. following oral application.

Winterhoff H, Gumbinger HG, Vahlensieck U, Kemper FH, Schmitz H, Behnke B.

Arzneimittelforschung. 1994 Jan;44(1):41-5.

PMID:
8135877
29.

Metabolism of caffeic acid in the isolated perfused rat liver.

Gumbinger HG, Vahlensieck U, Winterhoff H.

Planta Med. 1993 Dec;59(6):491-3.

PMID:
8302944

Supplemental Content

Loading ...
Support Center